| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/21/2004 | EP1410807A1 Methods and compositions useful for inhibition of angiogenesis |
| 04/21/2004 | EP1410804A1 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 04/21/2004 | EP1410799A1 Methods and pharmaceutical compositions for inhibiting tumour cell growth |
| 04/21/2004 | EP1410798A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 04/21/2004 | EP1410796A2 New therapeutic uses for potassium channel openers |
| 04/21/2004 | EP1410040A2 Method for identifying substances which modulate interleukin 4 (il-4) signaling |
| 04/21/2004 | EP1410035A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 04/21/2004 | EP1410022A2 Detection and treatment of prostate cancer |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409737A2 Methods for detecting and treating the early onset of aging-related conditions |
| 04/21/2004 | EP1409683A2 i HELICOBACTER /i PROTEINS, NUCLEIC ACIDS AND USES THEREOF |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409675A1 Gene involved in apoptosis regulation |
| 04/21/2004 | EP1409672A2 Antisense oligonucleotides which can inhibit the formation of capillary tubes by endothelial cells |
| 04/21/2004 | EP1409661A2 Hdac9 polypeptides and polynucleotides and uses thereof |
| 04/21/2004 | EP1409660A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409647A2 Composite scaffolds and methods using same for generating complex tissue grafts |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409639A1 Epidermal growth factor receptorantisense oligonucleotides |
| 04/21/2004 | EP1409550A1 Extracellular messengers |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409525A2 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket |
| 04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 04/21/2004 | EP1409446A1 Method for the nitration of phenolic compounds |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409076A2 Method and apparatus for treating tumors using low strength electric fields |
| 04/21/2004 | EP1409016A2 Antibodies to opgl |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |
| 04/21/2004 | EP1409007A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/21/2004 | EP1409005A1 Modulators of notch signalling for use in immunotherapy |
| 04/21/2004 | EP1408999A1 Compositions addressing inflammation and/or degenerative disorders |
| 04/21/2004 | EP1408995A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 04/21/2004 | EP1408989A2 Method and material for treating immune diseases |
| 04/21/2004 | EP1408988A1 Compositions of orally administered nutritional supplements to repair articular cartilage |
| 04/21/2004 | EP1408983A2 Method of treating hyperproliferative diseases using active vitamin d analogues |
| 04/21/2004 | EP1408981A1 Methods for preventing antipsychotic-induced weight gain |
| 04/21/2004 | EP1408977A1 A combination therapy for the treatment of heart failure |
| 04/21/2004 | EP1408971A1 Novel quinolines and uses thereof |
| 04/21/2004 | EP1408967A2 Novel pharmaceutical compositions based on anticholinergic agents, corticosteroids and betamimetic agents for the treatment of inflammatory and/or obstructive respiratory tract diseases |
| 04/21/2004 | EP1408966A1 A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 04/21/2004 | EP1408965A2 Use of dual h3/m2 antagonists with a bipiperidinic structure in the treatment of cognition deficit disorders |
| 04/21/2004 | EP1408949A2 Glycine betaine and its use as anti-hemorrhagic agent |
| 04/21/2004 | EP1408942A1 Methods and clinical devices for the inhibition or prevention of mammalian cell growth |
| 04/21/2004 | EP1408939A1 Methods for preparation and use of 1 alpha,24(s)-dihydroxyvitamin d2 |
| 04/21/2004 | EP1408937A2 Use of antagonists or partial agonists of 5ht1a receptors for the preparation of a medicament for treatment and prevention of gastrointestinal diseases |
| 04/21/2004 | EP1408908A2 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 04/21/2004 | EP1408808A2 Methods for diagnosing and treating heart disease |
| 04/21/2004 | EP1408753A2 Compounds effecting neuron remodeling and assays for same |
| 04/21/2004 | EP1287355B1 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 04/21/2004 | EP1204412A4 Use of etodolac to treat cancer |
| 04/21/2004 | EP1178783B1 Device and use for increasing the transdermal permeation of medicaments |
| 04/21/2004 | EP1159004A4 Novel redox clamping agents and uses thereof |
| 04/21/2004 | EP1141019B1 Substance for producing highly effective anti-tumour medicaments and corresponding method |
| 04/21/2004 | EP1112074B1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
| 04/21/2004 | EP0941095B1 Improved pharmaceutical compositions |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | EP0900379B1 Receptor for underivatized, aqueous soluble beta(1-3)-glucan |
| 04/21/2004 | CN1491281A Neurotonin and use thereof |
| 04/21/2004 | CN1491117A Compositions containing inclusion complexes |
| 04/21/2004 | CN1491109A Medical compositions containing aspirin |
| 04/21/2004 | CN1491106A Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/21/2004 | CN1491105A Novel modified released formulation |
| 04/21/2004 | CN1491104A Novel modified release formulation |
| 04/21/2004 | CN1491102A Ophthalmic compositions |
| 04/21/2004 | CN1491089A Composition and method for smoke detoxification |
| 04/21/2004 | CN1490054A Targeted anticarious DNA vaccine and peparation thereof |
| 04/21/2004 | CN1490048A Method for improving oral drug living thing availability, composition and reagent box |
| 04/21/2004 | CN1146445C Materials and methods relating to diagnosis and treatment of pre-eclampsia and diabetes |
| 04/21/2004 | CN1146416C Use of H+, K+-ATPase inhibitor in treatment of nasal polyps |
| 04/21/2004 | CN1146414C Amino acid composition and use thereof in immunosuppression |
| 04/21/2004 | CN1146412C Use of re-intake inhibitor of noradrenalin in preparatino of medicine against antagonistic |
| 04/21/2004 | CN1146411C Use of 1,3-propanediol derivatives |
| 04/21/2004 | CN1146409C Fast decomposing pellets |
| 04/21/2004 | CN1146403C Active substance releasing system |
| 04/20/2004 | US6723854 Preparing intermediates for epithilone a and b, desoxyepothilone a and b, and analogues thereof; haloalkadienyl thiazoles, the aldehyde intermediates; phosphorus halomethylene transfer agent |
| 04/20/2004 | US6723754 Controlling pain using transferase inhibitor |
| 04/20/2004 | US6723748 Vision disorders; topical applying |
| 04/20/2004 | US6723740 Administering therapeutic amount of human peroxisome proliferator activated receptor delta agonist to lower triglycerides |
| 04/20/2004 | US6723712 For therpay of virus-associated cancer, or non-virus-associated cancer |
| 04/20/2004 | US6723706 Modified antisense nucleotides complementary to a section of the human Ha-ras gene |
| 04/20/2004 | US6723703 Administering powder or aerosol to nasal mucosa and osteomeatal complex |
| 04/20/2004 | US6723552 DNA encoding a human melanin concentrating hormone receptor (MCH1) and uses thereof |
| 04/20/2004 | US6723525 Methods and compositions for screening modulators of lipid kinases |
| 04/20/2004 | US6723511 Suppression of apoptosis in cell; obtain cells, incubate with blocking agent, monitor apoptosis in cells |
| 04/20/2004 | US6723354 Methods and means for preventing or treating inflammation or pruritis |
| 04/20/2004 | US6723341 Antibiotic product, use and formulation thereof |
| 04/20/2004 | US6723326 Topical compositions containing probiotic Bacillus bacteria, spores, and extracellular products and uses thereof |
| 04/20/2004 | US6723319 Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies |
| 04/20/2004 | CA2421976C Medicaments |
| 04/20/2004 | CA2310136C Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 04/20/2004 | CA2296336C Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| 04/17/2004 | CA2443370A1 Structures of substrate binding pockets of scf complexes |
| 04/15/2004 | WO2004031401A2 Novel tyrosine kinases inhibitors |
| 04/15/2004 | WO2004031143A2 Novel combination of a factor xa inhibitor and clopidogrel |
| 04/15/2004 | WO2004030743A2 Drug delivery device having coated microprojections incorporating vasoconstrictors |
| 04/15/2004 | WO2004030700A1 Solid preparation |
| 04/15/2004 | WO2004030689A1 Composition containing eosinophil cationic protein |